2023 Environmental, Social and Governance Report
Extracted ESG KPIs
KPIs are organized by ESG aspects.
The types of emissions and respective emissions data.
| Indicator | Unit | 2021 | 2022 | 2023 | 2024 | 2025 | Report Pages |
|---|---|---|---|---|---|---|---|
| Ammonia nitrogen | tonne | 14.9 | 9.3 | 10.6 | 357 | ||
| Chemical Oxygen Demand (COD) | tonne | 269.5 | 259 | 246.3 | 357 | ||
| Decrease amount of emission per RMB10000 of output value as compared with 2020 | % | 17% | 22% | 26% | 264 | ||
| Nitrogen oxides (NOx) | tonne | 135.7 | 101.2 | 81.6 | 357 | ||
| Nitrogen oxides (NOₓ) - Amount of emission per RMB10000 of output value | % | 45.35 | 263 | ||||
| Particulate matter | tonne | 22.9 | 16.5 | 12.4 | 357 | ||
| Particulate matter - Amount of emission per RMB10000 of output value | % | 50.72 | 263 | ||||
| Sulphur dioxide (SO2) | tonne | 45.4 | 29.4 | 34.1 | 357 | ||
| Sulphur dioxide (SO₂) - Amount of emission per RMB10000 of output value | % | 41.37 | 263 | ||||
| VOCs - Amount of emission per RMB10000 of output value | % | 30.59 | 263 | ||||
| Volatile organic compounds (VOC) | tonne | 46.4 | 26.4 | 35.5 | 357 |
Direct (Scope 1) and energy indirect (Scope 2) greenhouse gas emissions (in tonnes) and, where appropriate, intensity (e.g. per unit of production volume, per facility).
| Indicator | Unit | 2021 | 2022 | 2023 | Report Pages |
|---|---|---|---|---|---|
| Ammonia nitrogen - Amount of emission per RMB10000 of output value | % | 35.62 | 263 | ||
| Chemical Oxygen Demand (CODₙ) - Amount of emission per RMB10000 of output value | % | 40.2 | 263 | ||
| Direct greenhouse gas emissions (Scope 1) | CO2 equivalent (in tonnes) | 193239.7 | 196398.1 | 155807.28 | 357 |
| Indirect greenhouse gas emissions (Scope 2) | CO2 equivalent (in tonnes) | 342591.8 | 369261.9 | 358525.65 | 357 |
| Intensity of greenhouse gas emissions | CO2 equivalent (in tonnes)/RMB10000 | 0.4 | 0.395 | 0.365 | 357 |
| Reduction of greenhouse gas emission intensity compared to 2020 | 27% | 18 | |||
| Reduction of total greenhouse gas emissions compared to the previous year | tCO2e | 51327 | 18 | ||
| Total greenhouse gas emissions | CO2 equivalent (in tonnes), tCO2e | 535831.5 | 565660 | 514332.93 | 18, 357 |
Total hazardous waste produced (in tonnes) and, where appropriate, intensity (e.g. per unit of production volume, per facility).
| Indicator | Unit | 2021 | 2022 | 2023 | Report Pages |
|---|---|---|---|---|---|
| Fuzhou Fuxing: reduction in solid waste by filter press process improvement | percent | 60 | 271 | ||
| Hazardous waste - Amount of disposal per RMB10000 of output value | % | 25.33 | 263 | ||
| Hazardous waste intensity | kg/RMB10000 | 2.5 | 2.5 | 1.92 | 358 |
| Medical waste (HW02) and waste medicines (HW03) | tonne | 1789.2 | 1954 | 1676.1 | 358 |
| Other hazardous waste | tonne | 1448.3 | 1578.3 | 1032 | 358 |
| Total hazardous waste | tonne | 3237.5 | 3532.3 | 2708.2 | 358 |
| Total hazardous waste disposed | tonne | Not disclosed | 2688 | 2285.2 | 358 |
| Total hazardous waste recycled/reused | tonne | Not disclosed | 844.3 | 423 | 358 |
Total non-hazardous waste produced (in tonnes) and, where appropriate, intensity (e.g. per unit of production volume, per facility).
| Indicator | Unit | 2021 | 2022 | 2023 | Report Pages |
|---|---|---|---|---|---|
| Non-hazardous waste - Amount of disposal per RMB10000 of output value | % | 20.39 | 263 | ||
| Non-hazardous waste intensity | kg/RMB10000 | 92.2 | 80 | 73.4 | 358 |
| Total non-hazardous waste | tonne | 118154.8 | 114580.9 | 103491.2 | 358 |
Description of emissions target(s) set and steps taken to achieve them.
| Indicator | Unit | 2023 | Report Pages |
|---|---|---|---|
| 2023 target for reduction of greenhouse gas emission intensity | 17% | 18 | |
| Percentage reduction of total greenhouse gas emissions compared to 2020 | 10.45% | 18 |
Description of how hazardous and non-hazardous wastes are handled, and a description of reduction target(s) set and steps taken to achieve them.
| Indicator | Unit | 2021 | 2022 | 2023 | Report Pages |
|---|---|---|---|---|---|
| Fuzhou Fuxing: disposal cost savings from filter press process improvement | million RMB | 1 | 271 | ||
| Fuzhou Fuxing: disposal cost savings from fungi residue reduction program | million RMB | 1 | 271 | ||
| Jiaozuo Hecheng: expected recycling of triethylamine raw materials | tonnes | 157 | 290 | ||
| Total non-hazardous waste disposed | tonne | 116301.8 | 103750.4 | 56229.3 | 358 |
| Total non-hazardous waste recycled/reused | tonne | 1853 | 10830.5 | 47261.9 | 358 |
Direct and/or indirect energy consumption by type (e.g. electricity, gas or oil) in total (kWh in '000s) and intensity (e.g. per unit of production volume, per facility).
| Indicator | Unit | 2021 | 2022 | 2023 | Report Pages |
|---|---|---|---|---|---|
| Biomass fuel consumption | tonne | 14.4 | 9.9 | 1.004 | 360 |
| Coal consumption (direct energy) | tonne | 8691 | 88244.2 | 66894.5 | 359 |
| Diesel consumption (direct energy) | liter | 328065.6 | 165774.7 | 206607.4 | 359 |
| Direct energy consumption | MWh | 572945.5 | 580898.6 | 472417.4 | 360 |
| Electricity - Amount of consumption per RMB10000 of output value | % | 14.51 | 263 | ||
| Expected electricity saved by wastewater treatment process upgrade at Livzon Hecheng | kWh per year | 700000 | 282 | ||
| Gasoline consumption (direct energy) | liter | 284665.6 | 219086.4 | 266040.5 | 359 |
| Indirect energy consumption | MWh | 687587.4 | 744814.4 | 732589 | 360 |
| Intensity of purchased electricity (indirect energy) | kWh/RMB10000 | 311.1 | 295.9 | 295.48 | 359 |
| Intensity of total energy consumption | MWh/RMB10000 | 1 | 0.9 | 0.85 | 360 |
| Liquefied petroleum gas consumption (direct energy) | tonne | 7.9 | 6.8 | 3.7 | 359 |
| Natural gas consumption (direct energy) | 10000 cubic meters | 598.6 | 584.5 | 689.8 | 359 |
| Purchased electricity (indirect energy) | kWh | 398439861.9 | 423624184.5 | 416608822.9 | 359 |
| Purchased steam (indirect energy) | tonne | 376140.5 | 416061.3 | 411261.6 | 359 |
| Solar power (purchased) consumption | kWh | Not disclosed | 235701 | 1192325.8 | 360 |
| Solar power (self-use) consumption | kWh | 692280 | 1044773 | 431250 | 360 |
| Total energy consumption | MWh | 1260532.9 | 1325713 | 1205006.4 | 360 |
| Total non-renewable energy consumption | MWh | Not disclosed | 1324392.2 | 1199298.2 | 359 |
| Total renewable energy consumption | MWh | Not disclosed | 1320.8 | 5708.2 | 360 |
Water consumption in total and intensity (e.g. per unit of production volume, per facility).
| Indicator | Unit | 2021 | 2022 | 2023 | Report Pages |
|---|---|---|---|---|---|
| Consumption of municipal water supplies (or from other water utilities) (A) | tonne | 5189580.3 | 4452079.5 | 361 | |
| Fresh groundwater consumption (C) | tonne | 215184 | 1573530 | 361 | |
| Fresh surface water consumption (B) | tonne | 243835 | 179227 | 361 | |
| Fresh water consumption = A+B+C | tonne | 6096512.8 | 5648599.3 | 6204836.5 | 361 |
| Industrial wastewater | tonne | 4222683.5 | 4530994.9 | 4921781.5 | 357 |
| Intensity of water consumption (fresh water) | tonne/RMB10000 | 4.8 | 4 | 4.4 | 361 |
| Reclaimed water consumption | tonne | 2400 | 64836 | 91952 | 361 |
| Total water consumption | tonne | 5648599.3 | 6204836.5 | 361 | |
| Water - Amount of consumption per RMB10000 of output value | % | 18.6 | 263 |
Description of energy use efficiency target(s) set and steps taken to achieve them.
| Indicator | Unit | 2023 | Report Pages |
|---|---|---|---|
| Coal saved by biomass boiler and tail gas treatment upgrade at Gutian Fuxing | tonnes per year | 1000 | 282 |
| Electricity expected to be saved by new air compressor equipment replacement, Ningxia Pharma | kWh per year | 3168000 | 284 |
| Electricity saved by air levitation blower replacement at Gutian Fuxing | kWh per year | 300000 | 282 |
| Electricity saved by efficient cooling station control system technological upgrade, Pharmaceutical Factory | kWh per year | 900000 | 284 |
| Electricity saved by equipment replacement in fermentation workshop 103, Ningxia Pharma | kWh per year | 1040000 | 284 |
| Electricity saved by high-efficiency pump installation at Gutian Fuxing | kWh per year | 100000 | 282 |
| Electricity saved by magnetic levitation blower replacement at Livzon Hecheng | kWh per year | 210000 | 282 |
| Natural gas saved by boiler replacement at Livzon Hecheng | cubic meters per year | 300000 | 282 |
| Steam expected to be saved by compressor modification technological upgrade, Pharmaceutical Factory | tonnes of steam per year | 210 | 284 |
| Steam expected to be saved by hot water system part of technological upgrade, Ningxia Pharma | tonnes of steam per year | 6000 | 284 |
| Steam saved by heating water part of technological upgrade in dormitories and office area, Ningxia Pharma | tonnes of steam per year | 5000 | 284 |
| Steam saved by steam trap leakage treatment at Gutian Fuxing | tonnes per year | 190 | 282 |
Description of whether there is any issue in sourcing water that is fit for purpose, water efficiency target(s) set and steps taken to achieve them.
| Indicator | Unit | 2022 | 2023 | Report Pages |
|---|---|---|---|---|
| Water recycling rate | % | 4.79 | 3.21 | 361 |
Total packaging material used for finished products (in tonnes) and, if applicable, with reference to per unit produced.
| Indicator | Unit | 2021 | 2022 | 2023 | Report Pages |
|---|---|---|---|---|---|
| Intensity of packaging material used | kg/RMB10000 | 7.9 | 9.16 | 10.01 | 361 |
| Other packaging material | tonne | 6370.8 | 8288.08 | 7988.44 | 361 |
| Paper packaging material | tonne | 3791.5 | 4829.83 | 6128.75 | 361 |
| Total packaging material used | tonne | 10162.3 | 13117.91 | 14117.2 | 361 |
Description of the significant impacts of activities on the environment and natural resources and the actions taken to manage them.
| Indicator | Unit | 2023 | Report Pages |
|---|---|---|---|
| Capitalized R&D investment as percentage of total R&D investment | % | 14.52% | 65 |
| Coverage of the operations certified to GB/T 24001-2016/ISO 14001:2015 Environmental Management System | 100% | 18 | |
| Environmental protection investment | million RMB | 78.87 | 18 |
| Investment in maintenance of environmental protection operation | million RMB | 68.21 | 18 |
| Investment in upgrade of environmental protection facilities | million RMB | 10.66 | 18 |
| MSCI ESG score | AAA | 18 |
Description of the significant climate-related issues which have impacted, and those which may impact, the issuer, and the actions taken to manage them.
| Indicator | Unit | 2023 | 2100 | Report Pages |
|---|---|---|---|---|
| CDP (Climate Change Questionnaire) score | B | 18 | ||
| CNI ESG score | AAA | 18 | ||
| Projected global temperature increase under SSP 1-2.6 scenario | °C above pre-industrial levels | 1.8 | 293 | |
| Projected global temperature increase under SSP 5-8.5 scenario | °C above pre-industrial levels | 4.5 | 293 | |
| Wind ESG score | AAA | 18 |
Total workforce by gender, employment type (for example, full- or part-time), age group and geographical region.
| Indicator | Unit | 2019 | 2020 | 2021 | 2021-2023 | 2022 | 2023 | Report Pages |
|---|---|---|---|---|---|---|---|---|
| Age - 30 and below (internal hires) | % | 37.5 | 34.7 | 365 | ||||
| Age - 31-49 (internal hires) | % | 59.55 | 61.79 | 365 | ||||
| Age - 50 and above (internal hires) | % | 2.95 | 3.51 | 365 | ||||
| Average percentage of women in executive management (2021-2023) | % | 26.19% | 195 | |||||
| Average share of women in executive management in each of the past three years | % | 25 | 25 | 26.2 | 363 | |||
| Average years employed for female employees | year/person | 7.7 | 7.67 | 364 | ||||
| Average years employed for male employees | year/person | 9.7 | 9.52 | 364 | ||||
| Employee category - Director level (internal hires) | % | 5.21 | 4.96 | 365 | ||||
| Employee category - General manager level and above (internal hires) | % | 0.17 | 1.81 | 365 | ||||
| Employee category - Manager level (internal hires) | % | 23.78 | 24.55 | 365 | ||||
| Employee category - Other employees (internal hires) | % | 70.83 | 68.68 | 365 | ||||
| Employees very satisfied with company gender equality | % | 74 | 237 | |||||
| Engagement scores for 4 subsidiaries exceeded best employer engagement level | % | 87 | 237 | |||||
| Gender - Female (internal hires) | % | 42.71 | 46.07 | 365 | ||||
| Gender - Male (internal hires) | % | 57.29 | 53.93 | 365 | ||||
| Geographical region - China's mainland (internal hires) | % | 99.83 | 100 | 365 | ||||
| Geographical region - Foreign nation (internal hires) | % | 0.17 | 365 | |||||
| Number of R&D employees | 729 | 911 | 936 | 973 | 906 | 65 | ||
| Number of administrative staff | employees | 546 | 186 | |||||
| Number of directors (excluding independent directors) and senior executives under first grant of 2022 Share Options Incentive Plan | persons | 8 | 227 | |||||
| Number of directors (excluding independent directors), supervisors and senior executives in Third Phase Ownership Plan | persons | 8 | 227 | |||||
| Number of employees aged 30 and below | employees, person | 3191 | 3424 | 3226 | 186, 362 | |||
| Number of employees aged 31-49 | employees, person | 4931 | 5066 | 5156 | 186, 362 | |||
| Number of employees aged 50 and above | employees, person | 458 | 515 | 551 | 186, 362 | |||
| Number of employees at director level | person | 182 | 168 | 183 | 362 | |||
| Number of employees at general manager level and above | person | 84 | 80 | 81 | 362 | |||
| Number of employees at manager level | person | 850 | 908 | 897 | 362 | |||
| Number of employees in China's mainland | person | 8569 | 8991 | 8921 | 362 | |||
| Number of employees in Hong Kong, Macao and Taiwan of China | person | 2 | 3 | 2 | 362 | |||
| Number of employees in executive management | person | 8 | 8 | 7 | 363 | |||
| Number of employees in foreign nation | person | 9 | 11 | 10 | 362 | |||
| Number of employees with college diploma | employees | 2718 | 186 | |||||
| Number of employees with less than a college diploma | employees | 2974 | 186 | |||||
| Number of employees with master's degree | employees | 499 | 186 | |||||
| Number of employees with undergraduate degree | employees | 2690 | 186 | |||||
| Number of ethnic minority employees | person | 540 | 547 | 363 | ||||
| Number of female employees | employees, person | 4088 | 4277 | 4230 | 186, 362 | |||
| Number of financial staff | employees | 175 | 186 | |||||
| Number of male employees | employees, person | 4492 | 4728 | 4703 | 186, 362 | |||
| Number of new hires - Director level | person | 12 | 8 | 364 | ||||
| Number of new hires - Female | person | 1145 | 1028 | 364 | ||||
| Number of new hires - General manager level and above | person | 3 | 3 | 364 | ||||
| Number of new hires - Male | person | 1298 | 1210 | 364 | ||||
| Number of new hires - Manager level | person | 186 | 167 | 364 | ||||
| Number of new hires - Other employees | person | 2242 | 2060 | 364 | ||||
| Number of new hires aged 30 and below | person | 1578 | 1457 | 364 | ||||
| Number of new hires aged 31-49 | person | 852 | 765 | 364 | ||||
| Number of new hires aged 50 and above | person | 13 | 16 | 364 | ||||
| Number of new hires in China's mainland | person | 2439 | 2236 | 364 | ||||
| Number of new hires in Hong Kong, Macao and Taiwan of China | person | 2 | 1 | 364 | ||||
| Number of new hires in foreign nation | person | 2 | 1 | 364 | ||||
| Number of other employees | person | 7464 | 7849 | 7772 | 362 | |||
| Number of other employees in Third Phase Ownership Plan | persons | 76 | 227 | |||||
| Number of other employees under first grant of 2022 Share Options Incentive Plan | persons | 1018 | 227 | |||||
| Number of other employees under reserved grant of 2022 Share Options Incentive Plan | persons | 242 | 227 | |||||
| Number of production staff | employees | 5310 | 186 | |||||
| Number of sales staff | employees | 1756 | 186 | |||||
| Number of senior executives under reserved grant of 2022 Share Options Incentive Plan | persons | 1 | 227 | |||||
| Number of technical staff | employees | 1146 | 186 | |||||
| Number of women in executive management | employees, person | 2 | 2 | 2 | 195, 363 | |||
| Number of women in management | person | 397 | 415 | 363 | ||||
| Overall employee engagement score | % | 75 | 237 | |||||
| Percentage of R&D employees | % | 8.08% | 10.89% | 10.91% | 10.81% | 10.14% | 65 | |
| Percentage of R&D employees to the total number of employees | 10.14% | 16 | ||||||
| Percentage of R&D investment to total operating income | % | 8.82% | 9.41% | 12.63% | 11.10% | 9.94% | 65 | |
| Percentage of employees who reported that they feel 'actively engaged' or 'engaged' out of the total workforce | % | 72.39 | 75 | 368 | ||||
| Percentage of female directors | 9.09% | 17 | ||||||
| Percentage of female employees | % | 46.8% | 47.5% | 47.7% | 47.5% | 47.4% | 195 | |
| Percentage of female employees in total workforce | 47.35% | 17 | ||||||
| Percentage of internal hires | % | 19.08 | 26.98 | 365 | ||||
| Percentage of women in management positions | 35.75% | 17 | ||||||
| Percentage of women in the executive management | 28.57% | 17 | ||||||
| Proportion of R&D investment in operating income | 9.94% | 16 | ||||||
| Proportion of engaged employees above national average | percentage points | +8 | 237 | |||||
| Proportion of engaged employees above pharmaceutical industry level | percentage points | +6 | 237 | |||||
| Ratio of average base salary for the management (men: women) | 0.95:1 | 17 | ||||||
| Ratio of average base salary plus other cash incentives for the management (men: women) | 1.03:1 | 17 | ||||||
| Share of ethnic minority employees | % | 6 | 6.1 | 363 | ||||
| Share of ethnic minority employees in management | % | 3.4 | 3.1 | 363 | ||||
| Share of women at director level (i.e. share of women in middle management positions) | % | 31 | 29.5 | 363 | ||||
| Share of women at general manager level and above (i.e. share of women in top management positions) | % | 27.5 | 32.1 | 363 | ||||
| Share of women at manager level (i.e. share of women in junior management positions) | % | 35.6 | 37.4 | 363 | ||||
| Share of women in STEM-related positions | % | 60.2 | 58 | 363 | ||||
| Share of women in executive management | % | 25 | 25 | 28.6 | 363 | |||
| Share of women in management | % | 34.3 | 35.7 | 363 | ||||
| Share of women in management positions in revenue-generating functions | % | 24.9 | 25.9 | 363 | ||||
| Target of the Year set for the percentage of employees who reported that they feel 'actively engaged' or 'engaged' out of the total workforce | % | 75 | 76 | 368 | ||||
| Total number of employees | employees, person | 8580 | 9005 | 8933 | 186, 362 | |||
| Total number of female employees | employees | 4223 | 3975 | 4088 | 4277 | 4260 | 195 | |
| Total number of new hires | person | 2443 | 2238 | 364 | ||||
| Wages, bonuses, allowances, compensation, welfare, housing funds and social insurance paid to the employees | million RMB | 1582.87 | 16 |
Employee turnover rate by gender, age group and geographical region.
| Indicator | Unit | 2021 | 2022 | 2023 | Report Pages |
|---|---|---|---|---|---|
| Employee retention intention above national average | percentage points | +3 | 237 | ||
| Employee retention intention above pharmaceutical industry level | percentage points | +3 | 237 | ||
| Employee turnover rate - Age 30 and below | % | 12.35 | 12.98 | 17.66 | 366 |
| Employee turnover rate - Age 31-49 | % | 10.78 | 9.6 | 10.79 | 366 |
| Employee turnover rate - Age 50 and above | % | 2.34 | 4.03 | 3.95 | 366 |
| Employee turnover rate - China's mainland | % | 11.09 | 10.81 | 13.45 | 366 |
| Employee turnover rate - Director level | % | Not disclosed | 9.79 | 2.27 | 366 |
| Employee turnover rate - Female | % | 11.25 | 11.64 | 14.78 | 366 |
| Employee turnover rate - Foreign nation | % | 31.25 | 18.18 | 8.33 | 366 |
| Employee turnover rate - General manager level and above | % | Not disclosed | 1.15 | 2.41 | 366 |
| Employee turnover rate - Hong Kong, Macao and Taiwan of China | % | 25 | 25 | 366 | |
| Employee turnover rate - Male | % | 10.98 | 10.09 | 12.26 | 366 |
| Employee turnover rate - Manager level | % | Not disclosed | 13.9 | 13.49 | 366 |
| Employee turnover rate - Other employees | % | Not disclosed | 10.6 | 13.73 | 366 |
| Total employee turnover rate | % | 11.11 | 10.82 | 13.45 | 366 |
Number and rate of work-related fatalities occurred in each of the past three years including the reporting year.
| Indicator | Unit | 2023 | Report Pages |
|---|---|---|---|
| LTIFR of employees | LTIs/million hours worked | 0.13 | 249 |
Lost days due to work injury.
| Indicator | Unit | 2021 | 2022 | 2023 | Report Pages |
|---|---|---|---|---|---|
| Lost days due to work injury | day | 180 | 143 | 21 | 367 |
Description of occupational health and safety measures adopted, and how they are implemented and monitored.
| Indicator | Unit | 2021 | 2022 | 2023 | Report Pages |
|---|---|---|---|---|---|
| Coverage of the operations certified to GB/T 45001-2020/ISO 45001:2018 Occupational Health and Safety Management System | 100% | 17 | |||
| Investment in work safety and occupational health | million RMB | 27.16 | 17 | ||
| Investments in health | RMB10000 | 154.4 | 330.8 | 261.2 | 370 |
The percentage of employees trained by gender and employee category (e.g. senior management, middle management).
| Indicator | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | Report Pages |
|---|---|---|---|---|---|---|---|
| Employee engagement survey coverage | % | 100 | 237 | ||||
| Employee engagement survey response rate | % | 98 | 237 | ||||
| Number of doctors | employees | 52 | 186 | ||||
| Number of eligible participants in 2022 Share Options Incentive Plan | persons | 1269 | 227 | ||||
| Number of eligible participants under first grant of 2022 Share Options Incentive Plan | persons | 1026 | 227 | ||||
| Number of eligible participants under reserved grant of 2022 Share Options Incentive Plan | persons | 243 | 227 | ||||
| Number of employees participated in Third Phase Ownership Plan (Stock Ownership Plan) | persons | 84 | 227 | ||||
| Other inspections (drug preparation manufacturing enterprises) | inspections | 18 | 130 | ||||
| Percentage of employees trained by category: Director level | % | 2.12 | 1.87 | 2.05 | 367 | ||
| Percentage of employees trained by category: General manager level and above | % | 0.98 | 0.89 | 0.91 | 367 | ||
| Percentage of employees trained by category: Manager level | % | 9.91 | 10.08 | 10.04 | 367 | ||
| Percentage of employees trained by category: Other employees | % | 86.99 | 87.16 | 87 | 367 | ||
| Percentage of employees trained by gender: Female | % | 47.65 | 47.5 | 47.35 | 367 | ||
| Percentage of employees trained by gender: Male | % | 52.35 | 52.5 | 52.65 | 367 | ||
| Percentage of total employees who took part in training | % | 100 | 100 | 100 | 367 | ||
| R&D investment | RMB million | 827.13 | 909.59 | 1252.36 | 1047.27 | 1235.11 | 65 |
| R&D investment and its proportion in operating income | million RMB | 1235.11 | 16 |
The average training hours completed per employee by gender and employee category.
| Indicator | Unit | 2021 | 2022 | 2023 | Report Pages |
|---|---|---|---|---|---|
| Average amount spent per employee on training and development programs | RMB/person | 478.45 | 598.88 | 368 | |
| Average training hours completed per employee age 30 and below | hour/person | 77.5 | 106.6 | 368 | |
| Average training hours completed per employee age 31-49 | hour/person | 82 | 55.1 | 368 | |
| Average training hours completed per employee age 50 and above | hour/person | 79.4 | 65.4 | 368 | |
| Average training hours completed per employee in China's mainland | hour/person | 80.1 | 74.4 | 368 | |
| Average training hours completed per employee in Hong Kong, Macao and Taiwan of China | hour/person | 82.3 | 30.7 | 368 | |
| Average training hours completed per employee in foreign nation | hour/person | 77.9 | 26.4 | 368 | |
| Average training hours of employees | hours | 74.32 | 17 | ||
| Average training hours per employee | hour/person | 76.2 | 80.1 | 74.3 | 367 |
| Average training hours per employee by category: Director level | hour/person | 52.6 | 71 | 28.8 | 367 |
| Average training hours per employee by category: General manager level and above | hour/person | 16.9 | 51.6 | 12 | 367 |
| Average training hours per employee by category: Manager level | hour/person | 56.2 | 68 | 31.8 | 367 |
| Average training hours per employee by category: Other employees | hour/person | 79.7 | 82 | 80.9 | 367 |
| Average training hours per employee by gender: Female | hour/person | 76.2 | 80.1 | 80.1 | 367 |
| Average training hours per employee by gender: Male | hour/person | 76.2 | 80.1 | 69.2 | 367 |
| Average training hours per employee who participated in leadership training | hour/person | 4.6 | 36.7 | 368 | |
| Average training hours per employee who participated in management training | hour/person | 3.6 | 21.3 | 368 |
Number of suppliers by geographical region.
| Indicator | Unit | 2021 | 2022 | 2023 | Report Pages |
|---|---|---|---|---|---|
| Number of GMP compliant production lines | production lines | 52 | 128 | ||
| Number of suppliers in Central China | nos | 148 | 131 | 187 | 369 |
| Number of suppliers in Eastern China | nos | 837 | 724 | 797 | 369 |
| Number of suppliers in Northeastern China | nos | 30 | 31 | 30 | 369 |
| Number of suppliers in Northern China | nos | 196 | 188 | 194 | 369 |
| Number of suppliers in Northwestern China | nos | 99 | 92 | 111 | 369 |
| Number of suppliers in Southern China | nos | 689 | 667 | 709 | 369 |
| Number of suppliers in Southwestern China | nos | 47 | 36 | 47 | 369 |
| Number of suppliers in foreign countries | nos | 9 | 8 | 11 | 369 |
| Total number of suppliers | nos | 2055 | 1877 | 2086 | 369 |
Description of practices relating to engaging suppliers, number of suppliers where the practices are being implemented, and how they are implemented and monitored.
| Indicator | Unit | 2023 | Report Pages |
|---|---|---|---|
| License inspections (API manufacturing enterprises) | inspections | 5 | 130 |
| License inspections (drug preparation manufacturing enterprises) | inspections | 5 | 130 |
Description of practices used to identify environmental and social risks along the supply chain, and how they are implemented and monitored.
| Indicator | Unit | 2023 | Report Pages |
|---|---|---|---|
| On-site assessment of risk monitoring (in vitro diagnostic reagent enterprise) | assessment | 1 | 130 |
Percentage of total products sold or shipped subject to recalls for safety and health reasons.
| Indicator | Unit | 2023 | Report Pages |
|---|---|---|---|
| EU export certification inspection (API manufacturing enterprises) | inspection | 1 | 130 |
Number of products and service related complaints received and how they are dealt with.
| Indicator | Unit | 2021 | 2022 | 2023 | Report Pages |
|---|---|---|---|---|---|
| Equitable pricing policies based on local income levels in South Asia, Southeast Asia, South America, and Africa adopted for products | products | 27 | 16 | ||
| Market value of Infectious Disease Eight-Item Test Reagents in twenty-five provinces | billion RMB | 4.5 | 100 | ||
| Medication queries | nos | 9 | 20 | 17 | 369 |
| Number of Group products in class B list of Medical Insurance Catalogue | products | 98 | 10 | ||
| Number of Group products included in the Medical Insurance Catalogue | products | 190 | 10 | ||
| Number of products registered domestically | products | 152 | 128 | ||
| Number of registration projects completed for international registration of drug preparations | projects | 39 | 128 | ||
| On-site inspections of registration of pharmaceuticals for human use (API manufacturing enterprises) | inspections | 2 | 130 | ||
| On-site sampling and inspections of veterinary drugs (API manufacturing enterprises) | inspections | 2 | 130 | ||
| Overseas selling price per dose of Aripiprazole prolonged-action preparation (Otsuka, Japan) | RMB | 4000–26000 | 100 | ||
| Product-related complaints | nos | 142 | 77 | 80 | 369 |
Description of practices relating to observing and protecting intellectual property rights.
| Indicator | Unit | 2023 | Report Pages |
|---|---|---|---|
| Domestic registration of APIs | products | 58 | 129 |
| Domestic registration of in vitro diagnostic reagents | products | 147 | 129 |
| Domestic registration of in vitro diagnostic reagents - drug certificates | certificates | 9 | 129 |
| Domestic registration of in vitro diagnostic reagents - drugs | drugs | 7 | 129 |
| Domestic registration of in vitro diagnostic reagents - medical devices | medical devices | 140 | 129 |
| International certification of APIs - internationally certified varieties | varieties | 14 | 129 |
| International certification of APIs - internationally recognized certificates | certificates | 27 | 129 |
| International certification of in vitro diagnostic reagents - internationally certified varieties | varieties | 10 | 129 |
| International certification of in vitro diagnostic reagents - internationally recognized certificates | certificates | 5 | 129 |
| International registration of APIs | registration projects | 167 | 129 |
| International registration of APIs - countries/regions | countries/regions | 103 | 129 |
| International registration of APIs - products | products | 36 | 129 |
| International registration of in vitro diagnostic reagents | registration projects | 27 | 129 |
| International registration of in vitro diagnostic reagents - countries/regions | countries/regions | 40 | 129 |
| International registration of in vitro diagnostic reagents - products | products | 25 | 129 |
| MDSAP (Medical Device Single Audit Program) certification audit (in vitro diagnostic reagent enterprise) | audit | 1 | 130 |
| Number of countries/regions involved in international registration of drug preparations | countries/regions | 12 | 128 |
| Number of internationally certified varieties | varieties | 3 | 128 |
| Number of internationally recognized certificates obtained within validity period | certificates | 3 | 128 |
| Number of specifications of products for international registration | specifications | 23 | 128 |
| Price of ELISA in single-person tests as percentage of CLIA | % | <8 | 100 |
| Price reduction achieved in centralized volume-based procurement for Infectious Disease Eight-Item Test Reagents (Enzyme-Linked Immunosorbent Assay) | % | 50.1 | 100 |
| Price reduction for Ilaprazole Sodium for Injection within the year | percent | 11 | 10 |
| Price reduction for Triptorelin Acetate Microspheres for Injection compared to imported preparations | percent | 21 | 10 |
Description of quality assurance process and recall procedures.
| Indicator | Unit | 2023 | Report Pages |
|---|---|---|---|
| Annual audit of ISO 13485:2016 Quality Management System Certification for Medical Devices (in vitro diagnostic reagent enterprise) | audit | 1 | 130 |
| Daily supervision audits of medical devices (in vitro diagnostic reagent enterprise) | audits | 2 | 130 |
| GMP compliance status of API production lines | production lines | 74 | 129 |
| GMP compliance status of in vitro diagnostic reagent production lines | production lines | 2 | 129 |
| GMP recertification inspection by Mexican authority (API manufacturing enterprises) | inspection | 1 | 130 |
| ISO quality management system certification for APIs - GB/T 19001-2016/ISO 9001:2015 | enterprises | 3 | 129 |
| ISO quality management system certification for APIs - ISO 22000:2018 | enterprise | 1 | 129 |
| ISO quality management system certification for in vitro diagnostic reagents - ISO 13485:2016 | enterprise | 1 | 129 |
| Number of Group products in class A list of Medical Insurance Catalogue | products | 92 | 10 |
| Number of annual tests for Infectious Disease Eight-Item Test Reagents in twenty-five provinces (ELISA and CLIA) | tests | 520000000 | 100 |
| Number of annual tests using CLIA methodology | tests | 350000000 | 100 |
| Number of annual tests using ELISA methodology | tests | 170000000 | 100 |
| Products included in the National Medical Insurance Catalogue | 190 | 16 | |
| Routine inspections (API manufacturing enterprises) | inspections | 10 | 130 |
| Routine inspections (drug preparation manufacturing enterprises) | inspections | 14 | 130 |
| Unannounced inspection of drugs (in vitro diagnostic reagents) | inspection | 1 | 130 |
| Unannounced inspection of medical devices (in vitro diagnostic reagent enterprise) | inspection | 1 | 130 |
| Unannounced inspections (drug preparation manufacturing enterprises) | inspections | 5 | 130 |
Number of concluded legal cases regarding corrupt practices brought against the issuer or its employees during the reporting period and the outcomes of the cases.
| Indicator | Unit | 2023 | Report Pages |
|---|---|---|---|
| Number of shares purchased under Third Phase Ownership Plan | shares | 2077100 | 227 |
| Year-on-year increase in net profit attributable to shareholders | 2.32% | 16 |
Description of preventive measures and whistle-blowing procedures, and how they are implemented and monitored.
| Indicator | Unit | 2023 | Report Pages |
|---|---|---|---|
| Inspections from drug regulatory agencies accepted by API manufacturing enterprises | inspections | 21 | 130 |
| Inspections from drug regulatory agencies accepted by drug preparation manufacturing enterprises | inspections | 42 | 130 |
| Inspections from drug regulatory agencies accepted by in vitro diagnostic reagents (drugs) | inspection | 1 | 130 |
| Inspections from medical device regulatory agencies accepted by in vitro diagnostic reagent enterprise (medical devices) | inspections | 6 | 130 |
| Lock-up period for shares purchased under Stock Ownership Plan | months | 36 | 227 |
| Total inspections from external regulatory agencies accepted by Livzon | inspections | 70 | 130 |
Description of anti-corruption training provided to directors and staff.
| Indicator | Unit | 2021 | 2022 | 2023 | Report Pages |
|---|---|---|---|---|---|
| Number of directors who attended anti-corruption training | person | 8 | 11 | 11 | 370 |
| Number of employees who attended anti-corruption training | person | 8580 | 9005 | 8933 | 370 |
| Total number of hours of anti-corruption training provided to directors | hour | 11.5 | 22 | 22 | 370 |
| Total number of hours of anti-corruption training provided to employees | hour | 35375.9 | 22422.5 | 17020.7 | 370 |
Focus areas of contribution (e.g. education, environmental concerns, labour needs, health, culture, sport).
| Indicator | Unit | 2021 | 2022 | 2023 | Report Pages |
|---|---|---|---|---|---|
| Agreements signed in relation to the Public Welfare Program for Prevention and Treatment of Chronic Diseases | 26 | 17 | |||
| Investments in disaster relief | RMB10000 | 885.1 | 322.1 | 625.1 | 370 |
| Investments in education | RMB10000 | 645 | 61.5 | 560.2 | 370 |
| Investments in other areas | RMB10000 | 20.5 | 28.7 | 55.5 | 370 |
| Investments in rural revitalization and industrial assistance | RMB10000 | Not disclosed | 254.7 | 196.1 | 370 |
| Number of low-income people with chronic diseases receiving assistance | Nearly 20000 | 17 | |||
| Number of share options under first grant of 2022 Share Options Plan | shares | 17973500 | 227 | ||
| Number of share options under reserved grant of 2022 Share Options Plan | shares | 2000000 | 227 | ||
| S&P Global ESG score | 65 | 18 |
Resources contributed (e.g. money or time) to the focus area.
| Indicator | Unit | 2021 | 2022 | 2023 | Report Pages |
|---|---|---|---|---|---|
| Annual treatment cost of imported Aripiprazole prolonged-action preparation (Otsuka, Japan) | RMB | 50000–300000 | 100 | ||
| Cash donation | RMB10000 | 1349.8 | 373.1 | 1349.8 | 370 |
| Expenditure on charitable donation | million RMB | 16.98 | 17 | ||
| In-kind donation | RMB10000 | 595.4 | 624.7 | 348.3 | 370 |
| Social contribution per share | RMB per share | 3.4 | 16 | ||
| Tax revenue created for the country | million RMB | 1439.86 | 16 | ||
| Total charitable donation | RMB10000 | 1945.2 | 997.8 | 1698.1 | 370 |
| Total employee volunteering hours | hours | 8209 | 17 |
The types of emissions and respective emissions data.
| Standard Indicator | Unit | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Airborne Particulate Matter (PM) Emissions | tonne | 22.9 | 16.5 | 12.4 |
| NOₓ Emission Intensity (By Revenue) | % | 45.35 | ||
| NOₓ Emissions | tonne | 135.7 | 101.2 | 81.6 |
| PM Emission Intensity (By Revenue) | % | 50.72 | ||
| SOₓ Emission Intensity (By Revenue) | % | 41.37 | ||
| SOₓ Emissions | tonne | 45.4 | 29.4 | 34.1 |
Direct (Scope 1) and energy indirect (Scope 2) greenhouse gas emissions (in tonnes) and, where appropriate, intensity (e.g. per unit of production volume, per facility).
| Standard Indicator | Unit | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Direct GHG Emissions (Scope 1) | tonnes CO2 equivalent | 193239.7 | 196398.1 | 155807.28 |
| Indirect Energy Emissions (Scope 2) | tonnes CO2 equivalent | 342591.8 | 369261.9 | 358525.65 |
| Total GHG Emissions | tonnes CO2 equivalent | 535831.5 | 565660 | 514332.93 |
| Total GHG Emissions Intensity (By Revenue) | tonnes CO2 equivalent/RMB10000 | 0.4 | 0.395 | 0.365 |
Total hazardous waste produced (in tonnes) and, where appropriate, intensity (e.g. per unit of production volume, per facility).
| Standard Indicator | Unit | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Hazardous Waste Disposed | tonne | 2688 | 2285.2 | |
| Hazardous Waste Recycled | tonne | 844.3 | 423 | |
| Total Hazardous Waste | tonne | 3237.5 | 3532.3 | 2708.2 |
| Total Hazardous Waste Intensity (By Revenue) | kg/RMB10000 | 2.5 | 2.5 | 1.92 |
Total non-hazardous waste produced (in tonnes) and, where appropriate, intensity (e.g. per unit of production volume, per facility).
| Standard Indicator | Unit | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Non-Hazardous Waste Disposed | tonne | 118154.8 | 114580.9 | 103491.2 |
| Total Non-Hazardous Waste Intensity (By Revenue) | kg/RMB10000 | 92.2 | 80 | 73.4 |
Description of emissions target(s) set and steps taken to achieve them.
| Standard Indicator | Unit | 2023 |
|---|---|---|
| GHG Emissions Reduction Percentage Compared to Last Year | % | 10.45 |
| Percentage of Reduction in GHG Intensity Compared to Last Year | % | 17 |
Description of how hazardous and non-hazardous wastes are handled, and a description of reduction target(s) set and steps taken to achieve them.
| Standard Indicator | Unit | 2022 | 2023 |
|---|---|---|---|
| Non-Hazardous Waste Intensity Reduction Percentage Compared to Last Year | % | 10.8 | 45.8 |
Direct and/or indirect energy consumption by type (e.g. electricity, gas or oil) in total (kWh in '000s) and intensity (e.g. per unit of production volume, per facility).
| Standard Indicator | Unit | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Biomass Energy | tonne | 14.4 | 9.9 | 1.004 |
| Diesel Fuel Consumption | liter | 328065.6 | 165774.7 | 206607.4 |
| Energy Consumption Intensity (By Revenue) | MWh/RMB10000 | 1 | 0.9 | 0.85 |
| Gasoline Consumption | liter | 284665.6 | 219086.4 | 266040.5 |
| LPG Consumption | tonne | 7.9 | 6.8 | 3.7 |
| Natural Gas Consumption | 10000 cubic meters | 598.6 | 584.5 | 689.8 |
| Purchased Electricity | kWh | 398439861.9 | 423624184.5 | 416608822.9 |
| Purchased Electricity Intensity (By Revenue) | kWh/RMB10000 | 311.1 | 295.9 | 295.48 |
| Purchased Steam | tonne | 376140.5 | 416061.3 | 411261.6 |
| Renewable Energy Consumption | MWh | 1320.8 | 5708.2 | |
| Solar Energy | kWh | 692280 | 1270474 | 1623575.8 |
| Total Direct Energy Consumption | MWh | 572945.5 | 580898.6 | 472417.4 |
| Total Energy Consumption | MWh | 1260532.9 | 1325713 | 1205006.4 |
| Total Indirect Energy Consumption | MWh | 687587.4 | 744814.4 | 732589 |
| Total Non-Renewable Fuel Consumption | MWh | 1324392.2 | 1199298.2 |
Water consumption in total and intensity (e.g. per unit of production volume, per facility).
| Standard Indicator | Unit | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Discharge of Industrial Wastewater | tonne | 4222683.5 | 4530994.9 | 4921781.5 |
| Groundwater Withdrawal | tonne | 215184 | 1573530 | |
| Municipal Water Consumption | tonne | 5189580.3 | 4452079.5 | |
| Recycled Water Usage | tonne | 2400 | 64836 | 91952 |
| Surface Water Withdrawal | tonne | 243835 | 179227 | |
| Total Water Withdrawal | tonne | 6096512.8 | 5648599.3 | 6204836.5 |
| Water Consumption Intensity (By Revenue) | tonne/RMB10000 | 4.8 | 4 | 4.4 |
Description of energy use efficiency target(s) set and steps taken to achieve them.
| Standard Indicator | Unit | 2023 |
|---|---|---|
| Electricity Usage Reduction Compared to Last Year | kWh per year | 5718000 |
| Steam Usage Reduction Compared to Last Year | tonnes of steam per year | 11400 |
Total packaging material used for finished products (in tonnes) and, if applicable, with reference to per unit produced.
| Standard Indicator | Unit | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Packaging Material Consumption (Paper) | tonne | 3791.5 | 4829.83 | 6128.75 |
| Packaging Material Intensity (By Revenue) | kg/RMB10000 | 7.9 | 9.16 | 10.01 |
| Packaging Materials Consumed | tonne | 10162.3 | 13117.91 | 14117.2 |
Description of the significant impacts of activities on the environment and natural resources and the actions taken to manage them.
| Standard Indicator | Unit | 2023 |
|---|---|---|
| Total Investment in Ecological Restoration | million RMB | 78.87 |
Total workforce by gender, employment type (for example, full- or part-time), age group and geographical region.
| Standard Indicator | Unit | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Number of Bachelor's Degree Employees | employees | 2690 | ||||
| Number of Below Junior College Employees | employees | 2974 | ||||
| Number of Employees Aged 30-50 | employees | 4931 | 5066 | 5156 | ||
| Number of Employees Aged Above 50 | employees | 458 | 515 | 551 | ||
| Number of Employees Aged Below 30 | employees | 3191 | 3424 | 3226 | ||
| Number of Employees in Hong Kong | person | 2 | 3 | 2 | ||
| Number of Employees in Mainland China | person | 8569 | 8991 | 8921 | ||
| Number of Employees in Overseas | person | 9 | 11 | 10 | ||
| Number of Female Employees | employees | 4223 | 3975 | 4088 | 4277 | 4230 |
| Number of Male Employees | employees | 4492 | 4728 | 4703 | ||
| Number of Master's Degree Employees | employees | 499 | ||||
| Number of New Employees | person | 2443 | 2238 | |||
| Number of New Employees (Above 50) | person | 13 | 16 | |||
| Number of New Employees (Aged 30-50) | person | 852 | 765 | |||
| Number of New Employees (Aged Below 30) | person | 1578 | 1457 | |||
| Number of New Employees (Female) | person | 1145 | 1028 | |||
| Number of New Employees (Hong Kong) | person | 2 | 1 | |||
| Number of New Employees (Mainland China) | person | 2439 | 2236 | |||
| Number of New Employees (Male) | person | 1298 | 1210 | |||
| Number of New Employees (Overseas) | person | 2 | 1 | |||
| Number of Total Employees | employees | 9022 | 8580 | 9005 | 8933 | |
| Percentage of Female Employees | % | 46.8 | 47.5 | 47.7 | 47.5 | 47.4 |
Employee turnover rate by gender, age group and geographical region.
| Standard Indicator | Unit | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Turnover Rate of Employees Aged 30-50 | % | 10.78 | 9.6 | 10.79 |
| Turnover Rate of Employees Aged Above 50 | % | 2.34 | 4.03 | 3.95 |
| Turnover Rate of Employees Aged Below 30 | % | 12.35 | 12.98 | 17.66 |
| Turnover Rate of Employees in Mainland China | % | 11.09 | 10.81 | 13.45 |
| Turnover Rate of Female Employees | % | 11.25 | 11.64 | 14.78 |
| Turnover Rate of Male Employees | % | 10.98 | 10.09 | 12.26 |
| Turnover Rate of Total Employees | % | 11.11 | 10.82 | 13.45 |
Lost days due to work injury.
| Standard Indicator | Unit | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Lost Days Due to Work-related Injuries | day | 180 | 143 | 21 |
Description of occupational health and safety measures adopted, and how they are implemented and monitored.
| Standard Indicator | Unit | 2023 |
|---|---|---|
| Investment in Work Safety | RMB | 2716000 |
The percentage of employees trained by gender and employee category (e.g. senior management, middle management).
| Standard Indicator | Unit | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Percentage of Employees Trained | % | 100 | 100 | 100 |
| Percentage of Trained Female Employees | % | 47.65 | 47.5 | 47.35 |
| Percentage of Trained Male Employees | % | 52.35 | 52.5 | 52.65 |
The average training hours completed per employee by gender and employee category.
| Standard Indicator | Unit | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Average Training Hours (Director and Above) | hour/person | 52.6 | 71 | 28.8 |
| Average Training Hours (Employees Aged 30-50) | hour/person | 82 | 55.1 | |
| Average Training Hours (Employees Over 50) | hour/person | 79.4 | 65.4 | |
| Average Training Hours (Employees Under 30) | hour/person | 77.5 | 106.6 | |
| Average Training Hours (Female) | hour/person | 76.2 | 80.1 | 80.1 |
| Average Training Hours (General Staff) | hour/person | 79.7 | 82 | 80.9 |
| Average Training Hours (Hong Kong Employees) | hour/person | 82.3 | 30.7 | |
| Average Training Hours (Mainland China Employees) | hour/person | 80.1 | 74.4 | |
| Average Training Hours (Male) | hour/person | 76.2 | 80.1 | 69.2 |
| Average Training Hours (Middle Management) | hour/person | 56.2 | 68 | 31.8 |
| Average Training Hours (Senior Management) | hour/person | 16.9 | 51.6 | 12 |
| Average Training Hours per Employee | hour/person | 76.2 | 80.1 | 74.3 |
Number of suppliers by geographical region.
| Standard Indicator | Unit | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Number of Suppliers in Central China | nos | 148 | 131 | 187 |
| Number of Suppliers in East China | nos | 837 | 724 | 797 |
| Number of Suppliers in North China | nos | 196 | 188 | 194 |
| Number of Suppliers in Northeast China | nos | 30 | 31 | 30 |
| Number of Suppliers in Northwest China | nos | 99 | 92 | 111 |
| Number of Suppliers in Overseas | nos | 9 | 8 | 11 |
| Number of Suppliers in South China | nos | 689 | 667 | 709 |
| Number of Suppliers in Southwest China | nos | 47 | 36 | 47 |
| Number of Total Suppliers | nos | 2055 | 1877 | 2086 |
Description of practices used to identify environmental and social risks along the supply chain, and how they are implemented and monitored.
| Standard Indicator | Unit | 2023 |
|---|---|---|
| Number of Suppliers Participated in Sustainability Risk Assessment | assessment | 1 |
Number of products and service related complaints received and how they are dealt with.
| Standard Indicator | Unit | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Number of Products and Service Related Complaints | nos | 142 | 77 | 80 |
Description of anti-corruption training provided to directors and staff.
| Standard Indicator | Unit | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Average Anti-corruption Training Hours for Directors and Management | hour/person | 1.44 | 2 | 2 |
| Average Anti-corruption Training Hours for General Employees | hour/person | 4.12 | 2.49 | 1.91 |
| Number of Directors and Management Attendance for Anti-corruption Training | person | 8 | 11 | 11 |
| Number of General Employees Attendance for Anti-corruption Training | person | 8580 | 9005 | 8933 |
| Number of People Participated in Ethical Standards and Anti-corruption Training | person | 8588 | 9016 | 8944 |
| Total Anti-corruption Training Hours for Directors and Management | hour | 11.5 | 22 | 22 |
| Total Hours of Anti-corruption Training | hour | 35387.4 | 22444.5 | 17042.7 |
| Total Hours of Anti-corruption Training for Employees | hour | 35375.9 | 22422.5 | 17020.7 |
Resources contributed (e.g. money or time) to the focus area.
| Standard Indicator | Unit | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Total Cash Donations | RMB10000 | 1349.8 | 373.1 | 1349.8 |
| Total In-kind Donations | RMB10000 | 595.4 | 624.7 | 348.3 |
| Total Public Welfare Donations | RMB10000 | 1945.2 | 997.8 | 1698.1 |
| Total Volunteer Service Hours | hours | 8209 |